Genstar Capital to Acquire CRF Health from Vitruvian Partners and Combine with Bracket

LONDON and WAYNE, Pennsylvania, July 17, 2018 /PRNewswire/ --

Combined organization will bring together complementary strengths with a shared focus on accelerated customer value through patient-centric clinical technology solutions 

Genstar Capital, a leading investor in healthcare technology and services companies, is pleased to announce the acquisition of CRF Health, a global provider of eCOA and eConsent solutions for the life sciences industry. As part of the transaction, CRF will be combined with Bracket, a provider of software and technology-enabled solutions utilized in clinical trials. Bracket is a portfolio company of Genstar.

CRF Health has been majority-owned by Vitruvian Partners, a leading growth-and technology-focused investment firm, since 2015.

The newly combined organization will drive accelerated value for pharmaceutical companies and CRO customers, providing patient-centric solutions, combined with deep and broad therapeutic area expertise, across a strong and efficient global footprint.

"CRF Health earned an outstanding reputation with 20 years of experience providing eCOA and now eConsent solutions to the biopharma industry around the world," said Mike Nolte, who will lead the combined organization as CEO. "CRF's technology and therapeutic experience dovetail well with our solutions, and they expand our ability to support increasingly complex clinical research. I am excited to bring two outstanding teams together to provide a reliable and scalable platform that accelerates the development of life changing medicines for our families and communities across the globe."

The combined company will have over 1,500 employees worldwide, and will be in a position to accelerate the penetration of user-friendly technologies across the clinical trial spectrum - driving the transfer from manual, paper based services to electronic while improving service quality and data integrity.

"This is an exciting step forward for patients, clients, and our new combined team," said Rachel Wyllie, CEO of CRF Health, who will become the Executive Chairman of the combined company. "The complementary nature of the two businesses provides us with the platform and scale for future growth in our dynamic markets, while ensuring our customers have more access to the latest patient-centric innovations in clinical research."